Insights

Important Changes in Healthcare Promoting Drug Price Transparency

Author

Confidio, Teams, Amber Capstick
Amber Capstick
Senior Account Executive

At Confidio, we are continuing to monitor the important changes in regulations regarding price transparency. The Federal Government will issue additional information regarding these changes in July 2021.

The three rules related to drug price transparency that were passed include the “Transparency in Coverage Rule” and “The No Surprises Act” and “Transparency”. The latter two are embedded in the “Consolidated Appropriations Act” (CAA).

The 3 key dates and requirements to be aware of for the “Transparency in Coverage Rule” are:

  • Effective 1/1/2022: Machine Readable Files – These files will be used by researchers, employer groups and third-party application developers to assist in understanding current and past historical pricing information.
  • Effective 1/1/2023: Member Price Comparison Tool for 500 services – Tool must be self-service browser based and provide real time out of pocket costs as well as prerequisites to coverage such as Prior Authorization and Step Therapy. The services for this first phase are still to be determined.
  • Effective 1/1/2024: Member Price Comparison Tool for all services – This phase is related to enhancing the Member Price Comparison Tool requirement for 1/1/2023. It should include ALL items and services covered. These services are yet to be determined but will likely include drug pricing.

The key date and requirement to be aware of for the Consolidated Appropriations Act is:

  • Effective 1/1/2022: Reporting on pharmacy benefits and drug costs including impact on premiums by rebates, fees and any renumeration paid by drug manufacturers.

We have sent Requests for Information out to our PBM partners to gather details regarding these changes and the services they may provide to clients to support compliance with the new regulations. We will keep you informed as we receive this information and any other guidance that may be helpful to you.

Download the PDF here.

 

 

Articles & Announcements

COVID Vaccine Update: Understanding Immunity and Potential for Boosters
FDA Approves Alzheimer’s Drug: Aduhelm
Confidio Expands Investment in Innovation and Continues to Grow Team
Important Changes in Healthcare Promoting Drug Price Transparency
COVID Vaccine Update
Breaking Down Barriers to Cancer Treatment: Problems and Solutions
Is your specialty drug management program only addressing half of your specialty spend?
The High Cost of Hemophilia A Treatments
Navigating HIV PrEP and the Affordable Care Act
Amazon launches “Amazon Pharmacy”, an online pharmacy store
The COVID Vaccine Derby: A Guide to the Top Contenders
Updated executive order on drug pricing, signed by President Trump
Confidio Hires 18 New Employees, Including 3 Strategic Executives
Are Brand-Name Drugs Safer Than Generics?
Understanding COVID-19’s Impact on pharmacy, the Economy and Our Future
President Trump’s Executive Orders on Drug Pricing
CONFIDIO Ranks No. 452 on the 2020 Inc. 5000 With Three-Year Revenue Growth of 1014.66%
Health Alert Updates: COVID-19
Emerging Treatments for Peanut Allergies
CONFIDIO NAMED TO INC. 5000 LIST
HHS Deploys Strategy to Import Drugs From Canada
White House reversal on Proposal to Eliminate Drug Rebates and Pushing Discounts to Point-of-Sale
BBJ’s Employee Benefits Administrators Listing
Will the Rebate Bubble Burst?
Valsartan Drug Recall Notice
Pharmacy Benefits 2020: Ready to Spend Half of Your Medical Plan Budget on Rx?
Pharmacy Predictions: 2019